<code id='D6F3CD16D1'></code><style id='D6F3CD16D1'></style>
    • <acronym id='D6F3CD16D1'></acronym>
      <center id='D6F3CD16D1'><center id='D6F3CD16D1'><tfoot id='D6F3CD16D1'></tfoot></center><abbr id='D6F3CD16D1'><dir id='D6F3CD16D1'><tfoot id='D6F3CD16D1'></tfoot><noframes id='D6F3CD16D1'>

    • <optgroup id='D6F3CD16D1'><strike id='D6F3CD16D1'><sup id='D6F3CD16D1'></sup></strike><code id='D6F3CD16D1'></code></optgroup>
        1. <b id='D6F3CD16D1'><label id='D6F3CD16D1'><select id='D6F3CD16D1'><dt id='D6F3CD16D1'><span id='D6F3CD16D1'></span></dt></select></label></b><u id='D6F3CD16D1'></u>
          <i id='D6F3CD16D1'><strike id='D6F3CD16D1'><tt id='D6F3CD16D1'><pre id='D6F3CD16D1'></pre></tt></strike></i>

          knowledge

          knowledge

          author:leisure time    Page View:1
          Alastair Grant/AP

          LONDON — AstraZeneca said Thursday it would purchase the French firm Amolyt Pharma in a deal worth up to $1 billion, picking up a rare disease drug in a pivotal trial.

          The acquisition includes an upfront payment of $800 million in cash, plus another $250 million if regulatory milestones are met. 

          advertisement

          AstraZeneca framed the deal for Amolyt, which has focused on treatments for rare endocrine diseases, as a boost for its own rare disease pipeline. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          Companies helping big Covid
          Companies helping big Covid

          AdobePfizerandModernaaren’ttheonlyvaccinemoney-makers.MuchoftherevenueandprofitsfromCovid-19vaccines

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

          2:08Sen.TommyTubervillespeakstoreportersintheSenatesubwayattheU.S.CapitolJuly10,2023inWashington,DC.